Chondroitin sulfate-E fine-tunes osteoblast differentiation via ERK1/2, Smad3 and Smad1/5/8 signaling by binding to N-cadherin and cadherin-11

Biochemical and Biophysical Research Communications

Volumn 420, Issue 3, 2012, Pages 523-529

  Koike, Toshiyasu ^a   Izumikawa, Tomomi ^a   Tamura, Jun Ichi ^b   Kitagawa, Hiroshi ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Cadherin; Chondroitin sulfate; Osteoblast differentiation; Proteoglycan; Signal transduction

Indexed keywords

CADHERIN; CADHERIN 11; CHONDROITIN SULFATE; CHONDROITIN SULFATE E; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE CELL ADHESION MOLECULE; NEUTRALIZING ANTIBODY; POLYSACCHARIDE; SMAD1 PROTEIN; SMAD3 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL ASSAY; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE OVEREXPRESSION; INHIBITION KINETICS; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; WESTERN BLOTTING;

CADHERINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHONDROITIN SULFATES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OSTEOBLASTS; OSTEOGENESIS; SMAD1 PROTEIN; SMAD3 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN;

VERTEBRATA;

EID: 84859591953     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.024     Document Type: Article

References (23)

1. Sugahara K., Kitagawa H. Recently advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans. Curr. Opin. Struct. Biol. 2000, 10:518-527.
2. Kitagawa H., Tsutsumi K., Tone Y., Sugahara K. Developmental regulation of the sulfation profile of chondroitin sulfate chains in the chicken embryo brain. J. Biol. Chem. 1997, 272:31377-31381.
3. Thiele H., Sakano M., Kitagawa H., et al. Loss of chondroitin 6-O-sulfotransferase-1 function results in severe human chondrodysplasia with progressive spinal involvement. Proc. Natl. Acad. Sci. USA 2004, 101:10155-10160.
4. Klüppel M., Wight T.N., Chan C., Hinek A., Wrana J.L. Maintenance of chondroitin sulfation balance by chondroitin-4-sulfotransferase 1 is required for chondrocyte development and growth factor signaling during cartilage morphogenesis. Development 2005, 132:3989-4003.
5. Miyata S., Komatsu Y., Yoshimura Y., Taya C., Kitagawa H. Persistent cortical plasticity by upregulation of chondroitin 6-sulfation. Nat. Neurosci. 2012, 15:414-422.
6. Uyama T., Kitagawa H., Tamura J., Sugahara K. Molecular cloning and expression of human chondroitin N-acetylgalactosaminyltransferase: the key enzyme for chain initiation and elongation of chondroitin/dermatan sulfate on the protein linkage region tetrasaccharide shared by heparin/heparan sulfate. J. Biol. Chem. 2002, 277:8841-8846.
7. Izumikawa T., Koike T., Kitagawa H. Chondroitin 4-O-sulfotransferase-2 regulates the number of chondroitin sulfate chains initiated by chondroitin N-acetylgalactosaminyltransferase-1. Biochem. J. 2012, 441:697-705.
8. Watanabe Y., Takeuchi K., Higa-Onaga S., et al. Chondroitin sulfate N-acetylgalactosaminyltransferase-1 is required for normal cartilage development. Biochem. J. 2010, 432:47-55.
9. Sudo H., Kodama H.A., Amagai Y., Yamamoto S., Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell. Biol. 1983, 96:191-198.
10. Miyazaki T., Miyauchi S., Tawada A., et al. Oversulfated chondroitin sulfate-E binds to BMP-4 and enhances osteoblast differentiation. J. Cell. Physiol. 2008, 217:769-777.
11. Takeichi M. Morphogenetic roles of classic cadherins. Curr. Opin. Cell. Biol. 1995, 7:619-627.
12. Cheng S.L., Shin C.S., Towler D.A., Civitelli R. A dominant negative cadherin inhibits osteoblast differentiation. J. Bone Miner. Res. 2000, 15:2362-2370.
13. Kii I., Amizuka N., Shimomura J., Saga Y., Kudo A. Cell-cell interaction mediated by cadherin-11 directly regulates the differentiation of mesenchymal cells into the cells of the osteo-lineage and the chondro-lineage. J. Bone Miner. Res. 2004, 19:1840-1849.
14. Tamura J., Tokuyoshi M. Synthesis of chondroitin sulfate E hexasaccharide in the repeating region by an effective elongation strategy toward longer chondroitin oligosaccharide. Biosci. Biotechnol. Biochem. 2004, 68:2436-2443.
15. Ohtake S., Kimata K., Habuchi O. A unique nonreducing terminal modification of chondroitin sulfate by N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase. J. Biol. Chem. 2003, 278:38443-38452.
16. Mikami T., Yasunaga D., Kitagawa H. Contactin-1 is a functional receptor for neuroregulatory chondroitin sulfate-E. J. Biol. Chem. 2009, 284:4494-4499.
17. Izumikawa T., Koike T., Shiozawa S., Sugahara K., Tamura J., Kitagawa H. Identification of chondroitin sulfate glucuronyltransferase as chondroitin synthase-3 involved in chondroitin polymerization: chondroitin polymerization is achieved by multiple enzyme complexes consisting of chondroitin synthase family members. J. Biol. Chem. 2008, 283:27333-27343.
18. Nadanaka S., Ishida M., Ikegami M., Kitagawa H. Chondroitin 4-O-sulfotransferase-1 modulates Wnt-3a signaling through control of E disaccharide expression of chondroitin sulfate. J. Biol. Chem. 2008, 283:11396-11406.
19. Nadanaka S., Kinouchi H., Taniguchi-Morita K., Tamura J., Kitagawa H. Down-regulation of chondroitin 4-O-sulfotransferase-1 by Wnt signaling triggers diffusion of Wnt-3a. J. Biol. Chem. 2011, 286:4199-4208.
20. Haÿ E., Nouraud A., Marie P.J. N-cadherin negatively regulates osteoblast proliferation and survival by antagonizing Wnt, ERK and PI3K/Akt signaling. PLoS One 2009, 4:e8284.
21. Sowa H., Kaji H., Yamaguchi T., Sugimoto T., Chihara K. Activations of ERK1/2 and JNK by transforming growth factor beta negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells. J. Biol. Chem. 2002, 277:36024-36031.
22. Hisa I., Inoue Y., Hendy G.N., et al. Parathyroid hormone-responsive Smad3-related factor, Tmem119, promotes osteoblast differentiation and interacts with the bone morphogenetic protein-Runx2 pathway. J. Biol. Chem. 2011, 286:9787-9796.
23. Rodan G.A., Martin T.J. Therapeutic approaches to bone diseases. Science 2000, 289:1508-1514.